mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.006 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.008 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.008 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.009 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.009 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |